BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16412232)

  • 1. Sequential boundaries approach in clinical trials with unequal allocation ratios.
    Jafari P; Ayatollahi SM; Behboodian J
    BMC Med Res Methodol; 2006 Jan; 6():1. PubMed ID: 16412232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of four sequential methods allowing for early stopping of comparative clinical trials.
    Sebille V; Bellissant E
    Clin Sci (Lond); 2000 May; 98(5):569-78. PubMed ID: 10781388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a mis-specification of the response rate under standard treatment in sequential clinical trials.
    Sébille V; Bellissant E
    Fundam Clin Pharmacol; 2005 Oct; 19(5):569-78. PubMed ID: 16176336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential analysis of latent variables using mixed-effect latent variable models: Impact of non-informative and informative missing data.
    Sébille V; Hardouin JB; Mesbah M
    Stat Med; 2007 Nov; 26(27):4889-904. PubMed ID: 17576119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robustness of an odds-ratio test in a stratified group sequential trial with a binary outcome measure.
    Srivastava DK; Rai SN; Pan J
    Biom J; 2007 Jun; 49(3):351-64. PubMed ID: 17623341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group sequential t-test for clinical trials with small sample sizes across stages.
    Shao J; Feng H
    Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size determination for comparing several survival curves with unequal allocations.
    Halabi S; Singh B
    Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reassessment of trial perspectives from interim data--a critical view.
    Bauer P; Koenig F
    Stat Med; 2006 Jan; 25(1):23-36. PubMed ID: 16220517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stopping boundaries adjusted for sample size reestimation and negative stop.
    Shun Z
    J Biopharm Stat; 2002 Nov; 12(4):485-502. PubMed ID: 12477071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of sequential methods in randomized clinical trials with censored response criteria].
    Benichou J; Chastang C
    Rev Epidemiol Sante Publique; 1986; 34(3):196-208. PubMed ID: 3786877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Design and analysis of phase II trials in oncology with a group sequential method, the triangular test].
    Bellissant E; Bénichou J; Chastang C
    Therapie; 1991; 46(1):21-7. PubMed ID: 2020920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing type I & type II error spending for two-sided group sequential designs.
    Rudser KD; Emerson SS
    Contemp Clin Trials; 2008 May; 29(3):351-8. PubMed ID: 17933592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplicity-adjusted sample size requirements: a strategy to maintain statistical power with Bonferroni adjustments.
    Leon AC
    J Clin Psychiatry; 2004 Nov; 65(11):1511-4. PubMed ID: 15554764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-designing trial combined with classical group sequential monitoring.
    Yin G; Shen Y
    J Biopharm Stat; 2005; 15(4):667-75. PubMed ID: 16022171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An algorithm for the design of group sequential triangular tests for single-arm clinical trials with a binary endpoint.
    McWilliams TP
    Stat Med; 2010 Nov; 29(27):2794-801. PubMed ID: 20860065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of the triangular test with response-adaptive treatment allocation.
    Coad DS; Ivanova A
    Stat Med; 2005 May; 24(10):1483-93. PubMed ID: 15706635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size for two-stage studies with maintenance therapy.
    Feng W; Wahed AS
    Stat Med; 2009 Jul; 28(15):2028-41. PubMed ID: 19382105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Information-based monitoring of clinical trials.
    Tsiatis AA
    Stat Med; 2006 Oct; 25(19):3236-44; discussion 3320-5, 3326-47. PubMed ID: 16927248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.